BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Innovative Biosensors, Inc. Announces Departure of President & CEO, Joe Hernandez


8/11/2009 7:16:55 AM

Bookmark and Share

ROCKVILLE, Md.--(BUSINESS WIRE)--Joe Hernandez, Founder, President & CEO of Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, announced his resignation effective August 7, 2009. Hernandez will continue to advise the company for several months thereafter.

“During my five years as CEO of IBI, we raised over $17M from sophisticated venture capitalists, we have deployed the technology protecting a portion of the Nation’s critical infrastructure, we began to develop clinical assays of great importance to the nosocomial market, and entered into relationships with numerous key partners,” said Hernandez. “It has been an honor and a privilege to work with the staff, the great scientists and investors who are so passionate about the work they do.”

“The board accepts Joe Hernandez’s decision with understanding and great appreciation for his service,” said Caroline Popper, Chair of IBI’s Board. “Under his leadership, IBI was able to develop and launch instruments into the biosecurity space and helped pave the way for the technology’s application in human clinical diagnostics.”

Effective with Mr. Hernandez’s departure, David Yost will serve as Division President of the company's Clinical Division, and Ted Olsen will serve as Division President of its Environmental Division. Additionally, Mr. Olsen, who is the company’s current Chief Operating Officer, will continue to serve in that capacity for both divisions while the Board of Directors engages in a search for Mr. Hernandez’s successor.

The search for Hernandez’s successor will begin immediately.

Contact:

Innovative Biosensors, Inc. (IBI) David Yost, 301-738-0604 dyost@innovativebiosensors.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->